market Inner Banner
  • BSE
  • NSE
    • {{d.cmpname}}
    • {{d.price}}
    • ticker-arrow
    • ({{d.PerChg}}%)
Equity | News | Hot Pursuit
Hot Pursuit
Blue Jet Healthcare jumps as Q4 PAT jumps 60% QoQ
Back
(10:41, 26 May 2026)
On a standalone basis, the company reported a net profit of Rs 64.34 crore in Q4 FY26, down 41.56% YoY but rising 60.17% QoQ.

Revenue from operations declined 31.07% YoY to Rs 234.67 crore in Q4 FY26 due to negligible sales of one molecule in the PI vertical. However, revenue increased 21.96% QoQ from Rs 192.41 crore driven by higher sales of advance contrast media.

The company said the YoY decline in revenue reflected timing-related order phasing in select PI accounts and customer-side inventory normalization. However, management maintained that underlying demand visibility remains strong and expects normalization in upcoming quarters.

Gross profit stood at Rs 132.5 crore in Q4 FY26, down 29.2% YoY but up 33% QoQ. Gross margin improved to 56.4% from 51.7% in Q3 FY26, supported by favourable product mix and higher sales of contrast media intermediates.

Profit before tax stood at Rs 87.15 crore in Q4 FY26, down 40.8% YoY while rising 62.05% QoQ.

EBITDA stood at Rs 71.3 crore in Q4 FY26, down 49.1% YoY but increasing 52% QoQ. EBITDA margin improved to 30.4% from 24.4% in Q3 FY26.

On the cost front, raw material costs declined 43.18% YoY to Rs 92.89 crore, while employee expenses increased 15.57% YoY to Rs 18.48 crore. Interest costs rose sharply to Rs 0.58 crore from Rs 0.03 crore a year ago, while depreciation expenses increased 30.51% YoY to Rs 6.46 crore.

For the full year FY26, net profit declined 18.8% YoY to Rs 247.82 crore, while revenue fell 8.03% YoY to Rs 947.32 crore. PBT for FY26 declined 18.12% YoY to Rs 332.51 crore.

EBITDA for FY26 stood at Rs 294.1 crore, down 22.1% YoY, while EBITDA margin moderated to 31% from 36.7% in FY25.

Net cash flow from operating activities improved sharply to Rs 334.14 crore in FY26 from Rs 45.76 crore in FY25.

The board recommended a final dividend of Rs 1.2 per equity share of the face value of Rs 2 each for the Financial Year ended 31 March 2026.

Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredient company and an end-to-end integrated Contract Development and Manufacturing Organisation (CDMO).

Powered by Capital Market - Live News

Top
Scores
Scores 2.O
Online Dispute Redressal (ODR)
Investor Charter
Invester Complaint
Advisory for Investors
Liquidity Enhancement Scheme
KYC documents in vernacular languages
KYC documents in vernacular languages of commodities
.
Stock Broker Name Registration Number Registered Address Branch Address Contact Number Email id
DB (International) Stock Brokers Limited INZ000179035 (BROKING)

IN-DP-CDSL-266-2004 (DEPOSITORY) 		Unit No. 210/211/211A at 2nd floor, Dalal Street Commercial Cooperative Society Ltd, Block No.53, Zone 5, Gift City, Gandhinagar, Gujarat-382355
51, Mini Market T/F Mandir Wali Gali, Yusaf Sarai, New Delhi 110016 011-35936102 greenpark@dbonline.in
C-12, DB Plaza, RDC Raj Nagar, Ghaziabad 201002 0120-4150393 ghaziabad@dbonline.in
Plot No 4, Wasme House, Film City Sector 16A, Noida – 201301 0120-4823200 compliance@dbonline.in
Out Side Jassusar Gate, Bikaner, Rajasthan – 334001 9001643408 bikaner@dbonline.in
Office No 101, City Center, Opp. High Court, M G Road, Indore 452001 9424083019 brajeshsadani@dbonline.in
203, Marshal House 25, Strand Road, Kolkata 700001 033-40055270 b032@dbonline.in
Shop No.-7, 2nd Floor, Amar Complex, Opp. Hanumaan Mandir, The Mall, Solan- 173212 6230604596 parwanoo@dbonline.in
Daga Commodities Private Limited INZ000028833 114, New Delhi House, 27 Barakhamba Road, Delhi 110001- 0120-4823200 compliance@dbonline.in
Daga Business (International) Stock Brokers (IFSC) Private Limited INZ000202436 Unit No. 228, Signature Building, Second Floor, Block 13B, Zone-1, Gift SEZ, Gandhinagar, Gujarat 382355 - 0120-4823200 compliance@dbonline.in

Disclosure regarding proprietary trading:

As required under Circular No. SEBI/MRD/SE/Cir-42/2003 dated 19.11.2003 issued by the Securities and Exchange Board of India; We hereby disclose that in addition to client based business, We are also doing proprietary trading.

Investor Grievances Email ID: investorgrievance@dbonline.in


Copyright © 2016 All rights Reserved DB (International) Stock Brokers Ltd.     Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors."          "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Attention Investors ::
subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries | Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. | Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors"